Stay updated on HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.

Latest updates to the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter updates show Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study status was updated to Completed on 2025-12-02. The Recruitment Status now shows Completed, replacing the previous Active, not recruiting entry.SummaryDifference0.3%

- Check31 days agoChange DetectedThe footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check38 days agoChange DetectedPage history shows a minor revision update from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. This banner removal does not change the study record content or status.SummaryDifference0.3%

- Check53 days agoChange DetectedNew history entry added on 2025-11-05 (Study Status) with the preceding revision dated 2025-10-31, increasing the record's version history to 79. A deletion entry from 2025-09-18 was also recorded.SummaryDifference0.2%

Stay in the know with updates to HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.